Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ballow

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Allergy and Asthma Proceedings|September 19, 2024
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomesMark Ballow
Immunology and Allergy Clinics of North America|July 14, 2020
Nuts and Bolts of Subcutaneous TherapyCarla Duff, Mark Ballow
Clinical Reviews in Allergy & Immunology|August 18, 2014
Biological Modulators in Eosinophilic DiseasesPanida Sriaroon, Mark Ballow
Clinical Immunology (Orlando, Fla.)|March 17, 2011
Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytesMark Ballow, Cheryl Allen
Journal of Investigational Allergology & Clinical Immunology|July 17, 2003
Role of cytokines in nasal polyposisHarcharan Singh, Mark Ballow
Immunology and Allergy Clinics of North America|October 12, 2015
Immunoglobulin Replacement Therapy for Primary ImmunodeficiencyPanida Sriaroon, Mark Ballow
The American Journal of Medicine|February 3, 2009
Atopic dermatitisNancy Wasserbauer, Mark Ballow
The Journal of Allergy and Clinical Immunology|April 8, 2010
Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseasesSusan Lee, Mark Ballow
The Journal of Allergy and Clinical Immunology|February 20, 2003
26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodiesRobert P Nelson, Mark Ballow
Clinical Reviews in Allergy & Immunology|June 25, 2021
Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune DysregulationMark Ballow, Jennifer W Leiding
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Allergy and Asthma Proceedings|September 19, 2024
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomesMark Ballow
Immunology and Allergy Clinics of North America|July 14, 2020
Nuts and Bolts of Subcutaneous TherapyCarla Duff, Mark Ballow
Clinical Reviews in Allergy & Immunology|August 18, 2014
Biological Modulators in Eosinophilic DiseasesPanida Sriaroon, Mark Ballow
Clinical Immunology (Orlando, Fla.)|March 17, 2011
Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytesMark Ballow, Cheryl Allen
Journal of Investigational Allergology & Clinical Immunology|July 17, 2003
Role of cytokines in nasal polyposisHarcharan Singh, Mark Ballow
Immunology and Allergy Clinics of North America|October 12, 2015
Immunoglobulin Replacement Therapy for Primary ImmunodeficiencyPanida Sriaroon, Mark Ballow
The American Journal of Medicine|February 3, 2009
Atopic dermatitisNancy Wasserbauer, Mark Ballow
The Journal of Allergy and Clinical Immunology|April 8, 2010
Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseasesSusan Lee, Mark Ballow
The Journal of Allergy and Clinical Immunology|February 20, 2003
26. Immunomodulation and immunotherapy: drugs, cytokines, cytokine receptors, and antibodiesRobert P Nelson, Mark Ballow
Clinical Reviews in Allergy & Immunology|June 25, 2021
Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune DysregulationMark Ballow, Jennifer W Leiding
Pageof 10